» Articles » PMID: 18991628

Cisplatin Cytotoxicity: DNA and Plasma Membrane Targets

Overview
Journal Curr Med Chem
Specialty Chemistry
Date 2008 Nov 11
PMID 18991628
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Most current anticancer therapies induce tumor cell death through apoptosis where its specific involved pathways are poorly understood. For example, for many DNA-damaging agents, the specific biochemical lesions (DNA adducts) are associated with the induction of apoptosis via the mitochondria death pathway. However, several of these DNA-damaging agents like cisplatin induce apoptosis through plasma membrane disruption, triggering the Fas death receptor pathway. In this review, we focus on the role of early plasma membrane events in cisplatin-induced apoptosis. Special attention is given to changes in plasma membrane fluidity, inhibition of NHE1 exchanger, activation of acid sphingomyelinase and their consequences on the Fas death pathway in response to cisplatin.

Citing Articles

The role of cisplatin in modulating the tumor immune microenvironment and its combination therapy strategies: a new approach to enhance anti-tumor efficacy.

Li G, Che X, Wang S, Liu D, Xie D, Jiang B Ann Med. 2025; 57(1):2447403.

PMID: 39757995 PMC: 11705547. DOI: 10.1080/07853890.2024.2447403.


Dihydroartemisinin-driven selective anti-lung cancer proliferation by binding to EGFR and inhibition of NRAS signaling pathway-induced DNA damage.

Li L, Peng X, Yang Z, Han N, Gou C, Shi J Sci Rep. 2024; 14(1):11704.

PMID: 38778121 PMC: 11111767. DOI: 10.1038/s41598-024-62126-8.


Integration of Network Pharmacology and Experimental Validation to Explore Jixueteng - Yinyanghuo Herb Pair Alleviate Cisplatin-Induced Myelosuppression.

Liu Y, Dai S, Xu Y, Xiang Y, Zhang Y, Xu Z Integr Cancer Ther. 2024; 23:15347354241237969.

PMID: 38462913 PMC: 10929034. DOI: 10.1177/15347354241237969.


Platinum-based drugs and hydrogel: a promising anti-tumor combination.

Yao J, Song S, Zhao H, Yuan Y Drug Deliv. 2023; 30(1):2287966.

PMID: 38083803 PMC: 10987050. DOI: 10.1080/10717544.2023.2287966.


PD-1/PD-L1 and DNA Damage Response in Cancer.

Kciuk M, Kolat D, Kaluzinska-Kolat Z, Gawrysiak M, Drozda R, Celik I Cells. 2023; 12(4).

PMID: 36831197 PMC: 9954559. DOI: 10.3390/cells12040530.